Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 12, 2022 06:43 ET | Source: Ocugen

COVAXIN™ (BBV152) Booster Shown to Neutralize Both Omicron and Delta Variants of SARS-CoV-2

Booster dose of candidate vaccine, COVAXIN™ (BBV152), generated robust neutralizing antibody responses against both Omicron (B.1.529) and Delta (B.1.617.2) using a live virus neutralization assay100%...
January 12, 2022 06:16 ET | Source: Vantage Market Research

2022 Statistics: U.S. and Global Nanotechnology in Medical Devices Market Will Surpass USD 1908 Million at 12.2% CAGR Growth: Vantage Market Research

WASHINGTON, Jan. 12, 2022 (GLOBE NEWSWIRE) -- The Global Nanotechnology in Medical Devices Market size is expected to reach USD 1,908 Million by 2028, exhibiting a CAGR of 12.2% during the forecast...
January 12, 2022 05:00 ET | Source: Graphical Research

Rare Sugar Market Size & Share | North America, Europe, & APAC Industry Forecasts 2026: Graphical Research

Pune, India, Jan. 12, 2022 (GLOBE NEWSWIRE) -- The global rare sugar market size is slated to register substantial growth rate during the forecast timeline, propelled by rising awareness among...
January 12, 2022 03:01 ET | Source: Mainz BioMed NV

Mainz Biomed Appoints Michele Pedrocchi, Former Head of Roche Diagnostics Business Development, to Strategic Advisory Board

BERKELEY, Calif. and MAINZ, Germany, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the...
January 12, 2022 02:54 ET | Source: Claritas HealthTech Pte. Ltd

Claritas HealthTech Receives FDA Clearance for Claritas iPET™ Software Solution for Improving Quality and Efficiency of PET scans

SINGAPORE and LONDON, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Claritas HealthTech Pte. Ltd. (“Claritas”), a healthcare technology company specializing in innovative deep-learning and advanced image...
January 12, 2022 02:00 ET | Source: iSTAR Medical

iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject

For immediate release iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject Pivotal trial of MINIject, STAR-V, now initiated in 13 sites across the USPositive feedback from...
January 12, 2022 01:00 ET | Source: F. Hoffmann-La Roche Ltd

Roche launches the cobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care

Roche launches the cobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care Handheld blood glucose...
January 11, 2022 20:26 ET | Source: Mesoblast Limited

Single Dose of Mesoblast’s Allogeneic Cell Therapy Provides Durable Pain Reduction for at Least Three Years in Patients With Degenerative Disc Disease

NEW YORK, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced 36-month follow-up...
January 11, 2022 19:03 ET | Source: Hagens Berman Sobol Shapiro LLP

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Talis Biomedical Corporation (TLIS) Investors to Contact Firm’s Attorneys, IPO-Related Securities Class Action Filed

SAN FRANCISCO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to submit your losses now. A securities class...
January 11, 2022 16:38 ET | Source: IR-Med, Inc.

IRME Letter to Shareholders

New York, N.Y., Jan. 11, 2022 (GLOBE NEWSWIRE) -- IR-Med, Inc. (OTCPINK: IRME). Our non-invasive monitoring technology enters the public eye – why I’m so excited for 2022. Dear new, old, and...
January 11, 2022 16:35 ET | Source: CytoDyn Inc.

CytoDyn to Hold Webcast and Live Q/A on January 13

VANCOUVER, Washington, Jan. 11, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the...
January 11, 2022 16:30 ET | Source: Cellectis Inc.

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

NEW YORK, 11 janv. 2022 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth Code ISIN : FR0010425595 DateNombre total d’actions composant le capital socialNombre total de droits de...
January 11, 2022 12:44 ET | Source: Access Vascular

Access Vascular Inc. Named 2022 BIG Innovation Award Winner

BEDFORD, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications, today announced it has been named a...
January 11, 2022 11:45 ET | Source: The Law Offices of Frank R. Cruz

DEADLINE ALERT for PSFE, BFT, RVNC, RAAS, and ORGO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, Jan. 11, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
January 11, 2022 11:30 ET | Source: TBRC Business Research PVT LTD

Companies In The Regenerative Medicine For Cartilage Market Increase R&D On Gene Therapy Technique As Per The Business Research Company's Regenerative Medicine For Cartilage Global Market Report 2022

LONDON, Jan. 11, 2022 (GLOBE NEWSWIRE) -- According to The Business Research Company’s research report on the regenerative medicine for cartilage market, gene therapies are most promising technique...
January 11, 2022 11:00 ET | Source: NeuroSigma, Inc.

NeuroSigma Announces Promotion of Dr. Colin Kealey to President

LOS ANGELES, Jan. 11, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced the promotion of Dr. Colin Kealey to President. NeuroSigma is the developer...
January 11, 2022 10:24 ET | Source: Visiongain Ltd

Animal Parasiticides Market Report Up to 2031: Visiongain Research Inc

Visiongain has published a new report on Animal Parasiticides Market Report to 2031. The global animal parasiticides market is segmented on the basis of type, by animal type, and by end-user. By type,...
January 11, 2022 10:09 ET | Source: Visiongain Ltd

Animal Nutrition Ingredients Market Report Up to 2031: Visiongain Research Inc

Visiongain has published a new report on Animal Nutrition Ingredients Market Report to 2031. The market is segmented on the basis of livestock, nutrients, and by end-user. By livestock, the market is...
January 11, 2022 10:06 ET | Source: Bronstein, Gewirtz & Grossman, LLC

Z, OWLT & DNA – Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Actions and Upcoming Deadlines

NEW YORK, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following...
January 11, 2022 10:00 ET | Source: OMID Holdings, Inc.

OMID Holdings, Inc. Engages with Marketing Firm

Phillipsburg, NJ, Jan. 11, 2022 (GLOBE NEWSWIRE) -- OMID Holdings, Inc. (OTC Pink: OMID) has entered into a 6-month marketing and consulting agreement with a Toronto-based marketing firm, North...
January 11, 2022 09:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2021 Results

LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced preliminary unaudited financial...
January 11, 2022 09:03 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces the Initiation of the T2Biothreat® Panel Clinical Trial

LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the initation of a U.S. clinical...
January 11, 2022 09:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces the Initiation of the T2Resistance® Panel Clinical Trial

LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the initiation of a U.S....
January 11, 2022 09:00 ET | Source: Emerald Health Pharmaceuticals

Emerald Health Pharmaceuticals Receives IND Clearance to Begin Phase 2 Clinical Trial of EHP-101 for Relapsing Forms of Multiple Sclerosis

SAN DIEGO, CA, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP or the Company), a clinical-stage biopharmaceutical company developing a new class of medicines to treat...
January 11, 2022 09:00 ET | Source: Revelation Biosciences, Inc.

Revelation Biosciences Inc. Announces Data Demonstrating REVTx-99 In Vitro Anti-Viral Activity Against SARS-CoV-2; Commencement of Trading as a Public Company

-A greater than 50% reduction in SARS-CoV-2 Delta viral load was observed- -REVTx-99 was tested prior to infection in multiple standard in vitro anti-viral activity assay systems- -Previously...
January 11, 2022 09:00 ET | Source: Syneos Health, Inc.

Syneos Health Releases 2022 Dealmakers’ Intentions Survey

MORRISVILLE, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 12th annual Dealmakers’...
January 11, 2022 09:00 ET | Source: GeoVax, Inc.

GeoVax Appoints Dr. Kelly McKee as Chief Medical Officer

Atlanta, GA, Jan. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies,...
January 11, 2022 08:15 ET | Source: Renalytix plc

Positive Study Results Published for KidneyIntelX™ in Monitoring Patient Response to New Drug Therapy

NEW YORK and SALT LAKE CITY, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Renalytix (NASDAQ: RNLX) (LSE: RENX) announced the publication of positive study results for KidneyIntelX™ as a risk monitoring tool to...
January 11, 2022 08:03 ET | Source: Pliant Therapeutics, Inc.

Pliant Therapeutics Highlights Recent Developments for Lead Program PLN-74809 and Expected 2022 Milestones

Enrollment complete in INTERGRIS-IPF Phase 2a clinical trial with top-line data expected mid-2022 FDA has authorized evaluation of long-term treatment with PLN-74809 at doses up to 320 mg in...
January 11, 2022 08:00 ET | Source: Harpoon Therapeutics

Harpoon Therapeutics Provides Pipeline Development Milestones for 2022

SOUTH SAN FRANCISCO, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today provided a...
January 11, 2022 08:00 ET | Source: electroCore, Inc.

electroCore, Inc. Broadens Patient Access to gammaCore with Launch of U.S. Telehealth Portal and Online Store

ROCKAWAY, N.J., Jan. 11, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the launch of an e-commerce shop for patients...
January 11, 2022 08:00 ET | Source: H-CYTE, Inc.

H-CYTE Enters Into Letter of Intent for Acquisition of Catheter Precision, Inc.

TAMPA, Fla., Jan. 11, 2022 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company, today announced that it has entered into a letter of intent for the acquisition of Catheter...
January 11, 2022 08:00 ET | Source: Cabaletta Bio

Cabaletta Bio Strengthens Executive Leadership Team with Promotions of Gwendolyn Binder, Ph.D. to President of Science and Technology and Arun Das, M.D. to Chief Business Officer

PHILADELPHIA, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for...
January 11, 2022 08:00 ET | Source: Aramis Biosciences

Aramis Biosciences Announces FDA Clearance of IND Application for A197, a Novel Immunomodulatory Agent for the Treatment of Dry Eye Disease

BOSTON, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Aramis Biosciences, Inc., a clinical-stage immuno-ophthalmology biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA)...
January 11, 2022 08:00 ET | Source: Eko

Eko Chief Medical Officer, Dr. Adam Saltman, Accepted into Forbes Technology Council

OAKLAND, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Eko, a cardiopulmonary digital health company, announced today that the company’s chief medical officer, Adam Saltman M.D., Ph.D., has joined the...
January 11, 2022 08:00 ET | Source: Applied Genetic Technologies Corporation

AGTC Exceeds Enrollment Target in SKYLINE Trial of AGTC-501 for the Treatment of X-linked Retinitis Pigmentosa (XLRP)

Company on track to report three-month interim study results, including visual acuity, visual sensitivity, mobility and safety data, in Q2 2022Company providing further updated guidance on other...
January 11, 2022 07:54 ET | Source: NRx Pharmaceuticals, Inc.

NRx Announces Planned Study Investigating BriLife™ Booster Vaccine Against Omicron Variant

Trial targeted to begin in the first quarter of 2022NRx is coordinating study with the US Health and Human Services Biomedical Advanced Research and Development Authority and several European...
January 11, 2022 07:30 ET | Source: KemPharm

KemPharm Announces Research Involving Serdexmethylphenidate to be Featured in Two Poster Presentations at the APSARD 2022 Annual Conference

Data highlight key pharmacokinetic properties of serdexmethylphenidate that are instrumental to its consistent and smooth release of d-MPH CELEBRATION, Fla., Jan. 11, 2022 (GLOBE NEWSWIRE) --...
January 11, 2022 07:30 ET | Source: Antares Pharma, Inc.

Antares Pharma Announces Positive Results From Phase I Study For ATRS-1902 For Adrenal Crisis Rescue

EWING, N.J., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today announced positive results from a Phase I study for...
January 11, 2022 07:12 ET | Source: Vir Biotechnology, Inc.

GSK and Vir Biotechnology Announce United States Government Agreement to Purchase Additional Supply of Sotrovimab, Authorized for the Early Treatment of COVID-19

– 600,000 additional doses to be supplied to the US government for distribution in Q1 2022, enabling further access to sotrovimab nationwide – – Brings total number of doses secured to date through...
January 11, 2022 07:00 ET | Source: Wesana Health

Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

CHICAGO and TORONTO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data driven life sciences company focused on developing...
January 11, 2022 07:00 ET | Source: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Initiates Enrollment in Clinical Trial of TNX-2100, a Diagnostic Skin Test to Measure Functional T Cell Immunity to SARS-CoV-2

Potential Uses Include: Biomarker of Immunity to SARS-CoV-2; Personalized Approach to Timing COVID-19 Vaccine Boosters; Public Health Surveillance; and Serving as an Endpoint for COVID-19 Vaccine...
January 11, 2022 07:00 ET | Source: Lucira Health Inc.

Lucira™ Check-It PCR-Quality, At-Home Molecular COVID-19 Test Now Available in the Optum Store

Lucira's COVID-19 test is the only EUA authorized rapid at-home self-test that delivers PCR accuracy and early detectability in a single-use test kit with results in 30 minutes Availability in the...
January 11, 2022 07:00 ET | Source: Bioventus, Inc.

Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue

DURHAM, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today preliminary revenue...
January 11, 2022 07:00 ET | Source: Black Diamond Therapeutics, Inc

Black Diamond Therapeutics Announces FDA Allowance of IND Application for BDTX-1535, A MasterKey Inhibitor of EGFR for the Treatment of Gliobastoma and Non-Small Cell Lung Cancer

CAMBRIDGE, Mass. and NEW YORK, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of...
January 11, 2022 07:00 ET | Source: Inivata

Inivata Announces RaDaR™ Assay Receives CE Mark and is Submitted for US Reimbursement via the MolDX Program

Inivata Announces RaDaR™ Assay Receives CE Mark and is Submitted for US Reimbursement via the MolDX Program Research Triangle Park, NC, USA and Cambridge, UK, 11 January 2022 -- Inivata, a leader...
January 11, 2022 07:00 ET | Source: Amryt Pharma plc

Amryt Announces Positive Long-Term Safety and Efficacy Data confirming the role for Mycapssa® (oral octreotide) in the management of Acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide

Amryt Announces Positive Long-Term Safety and Efficacy Data confirming the role for Mycapssa® (oral octreotide) in the management of Acromegaly patients who have responded to and tolerated treatment...
January 11, 2022 04:32 ET | Source: Blue California Ingredients

Following EFSA Ban of Food Additive Titanium Dioxide (TiO2), Blue California Launches Clean-label Food Grade Whitening Agents as Alternatives

Rancho Santa Margarita, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Following food authority EFSA’s ban of food additive titanium dioxide (TiO2), Blue California, the producer of natural science-based...
January 11, 2022 03:01 ET | Source: Mainz BioMed NV

Mainz Biomed to Present at the H.C. Wainwright Bioconnect Virtual Conference

BERKELEY, Calif. and MAINZ, Germany, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the...
January 11, 2022 02:30 ET | Source: GENinCode Plc

FDA Pre-Submission Filed for Cardio inCode-SCORE

OXFORD, England, Jan. 11, 2022 (GLOBE NEWSWIRE) -- GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the filing of its...